Related Experiment Video

Updated: Jun 6, 2025

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

855

Management of Patent Ductus Arteriosus Endarteritis in Children

Jane Canning1, Christopher Occleshaw2, Ajay J Iyengar3,4

  • 1Department of Paediatric Cardiology, Green Lane Paediatric and Congenital Cardiac Service, Auckland, New Zealand.

The Thoracic and Cardiovascular Surgeon Reports
|November 25, 2024
PubMed

Insights

Patent ductus arteriosus infective endarteritis (PDA-IE) is rare but challenging to diagnose and manage. This case study highlights a strategy to minimize complications in pediatric PDA-IE patients.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Medical Case Studies

Background:

  • Patent ductus arteriosus infective endarteritis (PDA-IE) risk reduced by antibiotics and interventions.
  • Despite advances, PDA-IE diagnosis and timely management remain challenging.
  • PDA-IE is a serious complication of untreated or inadequately treated PDA.

Observation:

  • A 9-year-old girl presented with PDA-IE.
  • The case illustrates the complexities in diagnosing and managing PDA-IE in pediatric populations.
  • Specific diagnostic and therapeutic strategies were employed.

Findings:

  • The presented strategy aimed to minimize complications associated with PDA-IE in a pediatric patient.
  • Successful management of a complex pediatric PDA-IE case was achieved.
  • The case underscores the importance of a tailored approach for PDA-IE.

Implications:

  • This case report offers valuable insights for clinicians managing pediatric PDA-IE.
  • The described strategy may help improve outcomes and reduce morbidity in similar cases.
  • Further research into optimal management protocols for pediatric PDA-IE is warranted.

Keywords:
endarteritismanagementpatent ductus arteriosus

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.6K
A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position11:20

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position

Published on: April 1, 2022

3.0K

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
2
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
135
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
4